HTLV type IIIB infection of human thymic epithelial cells: Viral expression correlates with the induction of NFκB-binding activity in cells activated by cell adhesion

AIDS Research and Human Retroviruses

Volumn 12, Issue 13, 1996, Pages 1217-1225

  Ramarli, Dunia ^a,d   Reina, Salvatore ^b   Merola, Marcello ^a   Scupoli, Maria Teresa ^a   Poffe, Ornella ^a   Riviera, Anna Pia ^a   Brentegani, Monica ^a   Fiorini, Emma ^a   Vella, Antonio ^a   Varnier, Oliviero ^b,c   Tridente, Giuseppe ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c CENTRO DI BIOTECNOLOGIE AVANZATE   (Italy)

^d Policlinico di Borgo Roma   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; TRANSCRIPTION FACTOR;

ARTICLE; CELL ADHESION; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOID CELL; PRIORITY JOURNAL; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 0029838415     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.1217     Document Type: Article

References (36)

1. Meyaard L, Schuitemaker H, and Miedema F: T-cell dysfunction in HIV infection: Anergy due to defective antigen-presenting cell function? Immunol Today 1993;14:161-164.
2. Pantaleo G, Graziosi C, Demarest JF, Cohen OJ, Vaccarezza M, Gantt K, Muro-Cacho C, and Fauci S: Role of lymphoid organs in the pathogenesis of human immunodeficiency virus (HIV) infection. Immunol Rev 1994;140:104-129.
3. Haynes BF, Scearee RM, Lobach DF, and Hensley LL: Phenotypic characterization and ontogeny of mesodermal-derived and endocrine epithelial components of the human thymic microenvironment. J Exp Med 1984;159:1149-1168.
4. Boyd RL, Tucek CL, Godfrey DI, Izon DJ, Wilson TJ, Davidson NJ, Bean AGD, Ladyman HM, Ritter MA, and Hugo P: The thymic microenvironment. Immunol Today 1993;14:445-459.
5. Schuurman HJ, Krone WJA, Broekhuizen R, Baarlen JV, van Veen P, Goldstein AL, Huber J, and Goudsmit J: The thymus in acquired immunodeficiency syndrome: Comparison with other types of immunodeficiency diseases, and presence of components of human immunodeficiency virus type 1. Am J Pathol 1989;134:1329-1338.
6. + depletion. Proc Natl Acad Sci USA 1990;87:7727-7731.
7. Stanley SK, McCune JM, Kaneshima H, Justement JS, Sullivan M, Boone E, Baseler M, Adelsberger J, Bonyhadi M, Orenstein J, Fox CH, and Fauci AS: Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse. J Exp Med 1993;178:1151-1163.
8. Bonyhadi ML, Su L, Auten J, McCune JM, and Kaneshima H: Development of a human thymic organ culture model for the study of HIV pathogenesis. AIDS Res Hum Retroviruses 1995;11: 1073-1080.
9. Numazaki K, Bai XQ, Goldman H, Wong I, Spira B, and Wainberg MA: Infection of cultured human thymic epithelial cells by immunodeficiency virus. Immunol Immunopathol 1989;51(2)185-195.
10. Schittman SM, Singer KH, Greenhouse JJ, Stanley SK, Whichard LP, Haynes BF, and Fauci AS: Thymic microenvironment induced HIV expression. J Immunol 1991;147:2553-2558.
11. Qian J, Bours V, Manischewitz J, Blackburn R, Siebenlist U, and Golding H: Chemically selected subclones of the CEM cell line demonstrate resistance to HIV-1 infection resulting from a selective loss of NF-κB DNA binding proteins. J Immunol 1994;152:4183-4191.
12. Nabel G and Baltimore D: An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature (London) 1987;316:711-714.
13. Vlach J and Pitha P: Activation of human immunodeficiency virus type 1 provirus in T-cells and macrophages is associated with induction of inducer specific NF-κB binding proteins. Virology 1992;187:63-72.
14. Green H, Kehinde O, and Thomas J: Growth of cultured human epidermal cells into multiple epithelia suitable for grafting. Proc Natl Acad Sci USA 1979;76:5665-5668.
15. Aoki S, Yarcoan R, Thomas RV, Pluda JM, Marzyk K, Broder S, and Mitsuya H: Quantitative analysis of HIV-1 proviral DNA in peripheral blood mononuclear cells from patients with AIDS or ARC: Decrease of proviral DNA content following treatment with 2′,3′ dideoxyinosine (ddI). AIDS Res Hum Retroviruses 1990;6: 1331-1339.
16. Giri A, Lillo FB, McDermott JL, Jannuzzi C, Risso S, Forni G, Concedi DR, and Vamier OE: Detection of HIV sequences in children using radiometric and colorimetric polymerase chain reaction. J Med Virol 1993;42:414-419.
17. Clouse KA, Powell D, Washington I, Poli G, Strebel K, Farrar W, Barstad P, Kovacs J, Fauci AS, and Folks T: Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone. J Immunol 1989;142:431-438.
18. Schreiber E, Matthias P, Muller MM, and Schaffner W: Rapid detection of octamer binding proteins with "mini extracts" prepared from a small number of cells. Nucleic Acids Res 1989;17:6419.
19. Sonnenberg A: Integrins and their ligands. Curr Topics Microbiol Immunol 1993;184:7-35.
20. Symington BE, Takada Y, and Carter WG: Interaction of integrins α3β1 and α2β1: Potential role in keratinocyte intercellular adhesion. J Cell Biol 1993;120:523-535.
21. Giunta M, Favre A, Ramarli D, Grossi C, and Corte G: A novel integrin is involved in thymocyte-thymic epithelial cell interaction. J Exp Med 1991;173:1537-1548.
22. Chan SH, Cosgrove D, Waltringer C, Benoist C, and Mathis D: Another view of the selective model of thymocyte selection. Cell 1993;73:225-236.
23. Le PTS, Lazorich S, Whichard LP, Yang YC, Clark SC, Haynes BF, and Singer KH: Human thymic epithelial cells produce IL-6, granulocyte-monocyte-CSF, and leukemia inhibitory factor. J Immunol 1990;145:3310-3315.
24. Poli G, Kinter AL, and Fauci AS: Interleukin-1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin-6 in chronically infected U1: Inhibition of inductive effects by the interleukin 1 receptor antagonist. Proc Natl Acad Sci USA 1994;91:108-112.
25. Poli G, Bressler P, Kinter A, Duh E, Timmer WC, Rabson A, Shawn J, Justement JS, Stanley S, and Fauci AS: Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor α by transcriptional and post-transcriptional mechanisms. J Exp Med 1990;172:151-158.
26. Couture C, Patel PC, and Potworowshy V: A novel thymic epithelial adhesion molecule. Eur J Immunol 1990;20:2769-2773.
27. Hynes RO: Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 1992;69:11-25.
28. Miyake S, Yagita H, Maruyama T, Hashimoto H, Miyasaka N, and Okumura K: β1 Integrin-mediated interaction with extracellular matrix proteins regulates cytokine gene expression in synovial fluid cells of rheumatoid arthritis patients. J Exp Med 1993;177: 863-867.
29. Couture C, Amarante-Mendez G, and Potworowshky EF: Tyrosine kinase activation in thymic epithelial cells: Necessity of thymocyte contact through the gp23/45/90 adhesion complex. Eur J Immunol 1992;22:2579-2585.
30. Le PT, Wollger LW, Haynes BF, and Singer KH: Ligand binding to the LFA-3 cell adhesion molecule induces IL-1 production by thymic epithelial cells. J Immunol 1990;144:4541-4547.
31. Bauerle P: The inducible transcription activator NF-κB: Regulation by distinct protein subunits. Biochim Biofis Acta 1991;1072: 63-80.
32. Grimm S and Bauerle P: The inducible transcription factor NF-κB: Structure-function relationship of its protein subunits. Biochem J 1993;290:297-308.
33. Gaynor R: Cellular transcription factors involved in the regulation of HIV-1 gene expression. AIDS 1992;6:347-363.
34. Tesmer VM, Rajadhyaksha A, Babin J, and Bina M: NF-IL6-mediated transcriptional activation of the long terminal repeat of the human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1993;90:7298-7302.
35. Kawakami K, Scheidereit C, and Roeder RG: Identification and purification of a human immunoglobulin-enhancer-binding protein (NF-κB) that activates transcription from a human immunodeficiency virus type 1 promoter in vitro. Proc Natl Acad Sci USA 1988;85:4700-4704.
36. Osborn L, Kunkel S, and Nabel G: Tumor necrosis factor alpha and interleukin 1 stimulate the human deficiency virus enhancer by activation of nuclear factors κB. Proc Natl Acad Sci USA 1989;86:2336-2340.